This beverage stock is likely to rise ahead of coffee business spinoff, Barclays says

Price Target Increase

$36

Barclays raised the price target for Keurig Dr Pepper shares from $30 to $36.

Projected Upside

15%

The new price target implies a 15% upside from the previous closing price.

Analyst Ratings Split

9 Buy / 9 Hold

Of the 18 analysts covering Keurig Dr Pepper, 9 have a buy or strong buy rating while 9 have a hold rating.

§ 01 Executive Snapshot

What: Keurig Dr Pepper stock is expected to rebound following an upgrade by Barclays ahead of its planned coffee business spinout.
Who: Barclays, Keurig Dr Pepper, Analyst Lauren Lieberman.
Why it matters: The successful execution of the spinout is crucial for investor confidence and stock performance.

Barclays upgraded Keurig Dr Pepper from equal weight to overweight and increased its price target from $30 to $36.
The upgrade implies a 15% upside from the stock's closing price on Wednesday.
Shares of Keurig Dr Pepper have fallen nearly 5% over the past year due to uncertainties regarding the coffee business spinout.

The planned spinout aims to create two distinct entities: Beverage Co. and Global Coffee Co. by early 2027.
Keurig Dr Pepper's acquisition of Dutch coffee and tea company JDE Peet's for approximately $18 billion reflects its strategic pivot in the coffee market.

Immediate market implications include a potential rebound in stock price as investor confidence grows in management's ability to successfully execute the spinout.
Long-term implications involve the separation of the coffee business potentially allowing for more focused growth strategies for both new entities.

Potential risks include ongoing market uncertainties and investor skepticism regarding the execution of the spinout strategy.
Competition from other beverage companies and market dynamics could impact the success of the new entities formed post-spinout.

Key milestones to watch include the execution of private credit financing and the mechanics of the separation ahead of the 2027 deadline.
Future analyst ratings and market performance will signal the success or failure of the planned spinout and its impact on stock valuation.

§ 07

What is the expected outcome for Keurig Dr Pepper stock?

Keurig Dr Pepper stock is expected to rebound following an upgrade by Barclays ahead of its planned coffee business spinout.

Why did Barclays upgrade Keurig Dr Pepper's stock rating?

Barclays upgraded Keurig Dr Pepper from equal weight to overweight due to the anticipated successful execution of the coffee business spinout.

When is the coffee business spinout expected to be completed?

The planned spinout aims to create two distinct entities by early 2027.

Who is the analyst responsible for the upgrade of Keurig Dr Pepper?

The upgrade was made by Barclays analyst Lauren Lieberman.